izpis_h1_title_alt

Discovery of benzothiazole scaffold-based DNA gyrase B inhibitors
ID Gjorgjieva, Marina (Avtor), ID Tomašič, Tihomir (Avtor), ID Barančokova, Michaela (Avtor), ID Katsamakas, Sotirios (Avtor), ID Ilaš, Janez (Avtor), ID Tammela, Päivi (Avtor), ID Peterlin-Mašič, Lucija (Avtor), ID Kikelj, Danijel (Avtor)

.pdfPDF - Predstavitvena datoteka, prenos (1,17 MB)
MD5: CC4F6ED8739ABAF99C7006C6F31FCFE6
.pdfPDF - Priloga, prenos (1,37 MB)
MD5: 287A1DC99C2941D7F398412E0AE06D2F
URLURL - Izvorni URL, za dostop obiščite http://pubs.acs.org/doi/abs/10.1021/acs.jmedchem.6b00864 Povezava se odpre v novem oknu

Izvleček
Bacterial DNA gyrase and topoisomerase IV control the topological state of DNA during replication and are validated targets for antibacterial drug discovery. Starting from our recently reported 4,5,6,7-tetrahydrobenzo[1,2-d]thiazole-based DNA gyrase B inhibitors, we replaced their central core with benzothiazole-2,6-diamine scaffold and interchanged substituents in positions 2 and 6. This resulted in equipotent nanomolar inhibitors of DNA gyrase from Escherichia coli displaying improved inhibition of Staphylococcus aureus DNA gyrase and topoisomerase IV from both bacteria. Compound 27 was the most balanced inhibitor of DNA gyrase and topoisomerase IV both from E. coli and S. aureus. The crystal structure of the 2-((2-(4,5-dibromo-1H-pyrrole-2-carboxamido)benzothiazol-6-yl)amino)-2-oxoacetic acid (24) in complex with E. coli DNA gyrase B revealed the binding mode of the inhibitor in the ATP-binding pocket. Only some compounds possessed weak antibacterial activity against Gram-positive bacteria. These results provide a basis for structure-based optimization towards dual DNA gyrase and topoisomerase IV inhibitors with antibacterial activity.

Jezik:Angleški jezik
Ključne besede:organoruthenium complexes, diketonates, anticancer drugs, ROS, cytotoxicity, cell cycle arrest
Tipologija:1.01 - Izvirni znanstveni članek
Organizacija:FFA - Fakulteta za farmacijo
Status publikacije:Objavljeno
Različica publikacije:Recenzirani rokopis
Leto izida:2016
Št. strani:Str. 8941-8954
Številčenje:Vol. 59, iss. 19
PID:20.500.12556/RUL-107604 Povezava se odpre v novem oknu
UDK:543:542:615
ISSN pri članku:0022-2623
DOI:10.1021/acs.jmedchem.6b00864 Povezava se odpre v novem oknu
COBISS.SI-ID:4145265 Povezava se odpre v novem oknu
Datum objave v RUL:06.05.2019
Število ogledov:2058
Število prenosov:1214
Metapodatki:XML RDF-CHPDL DC-XML DC-RDF
:
Kopiraj citat
Objavi na:Bookmark and Share

Gradivo je del revije

Naslov:Journal of medicinal chemistry
Skrajšan naslov:J. med. chem.
Založnik:American Chemical Society
ISSN:0022-2623
COBISS.SI-ID:25763328 Povezava se odpre v novem oknu

Sekundarni jezik

Jezik:Slovenski jezik
Ključne besede:bioanorganska kemija, koordinacijske spojine, organorutenijevi kompleksi, diketonati, citotoksičnost, protirakava zdravila

Projekti

Financer:EC - European Commission
Program financ.:H2020
Številka projekta:642620
Naslov:Interdisciplinary Training Network for Validation of Gram-Negative Antibacterial Targets
Akronim:INTEGRATE

Podobna dela

Podobna dela v RUL:
Podobna dela v drugih slovenskih zbirkah:

Nazaj